Year: 2017
Language: English
Author(s): World Federation of Hemophilia
At the WFH 2017 Global Forum in Montréal, David Page led a discussion between Alok Srivastava (India), Mark Skinner (USA), Margaret Ragni (USA), and Cedric Hermans (Belgium) to define the ideal clotting factor trough level for people with hemophilia, particularly in light of recent and ongoing advances in treatment options.
To learn more about factor trough levels in the context of novel therapies in the management of hemophilia, watch the other 2 videos of this panel discussion, Factor Trough Levels and Novel Hemophilia Therapies:
The WFH Shared Decision Making (SDM) Tool is an interactive decision-support system designed to facilitate discussions regarding treatment options between
This fact sheet contains commonly asked questions and more information on gene therapy for hemophilia B. Learn more about different
This video gives a quick introduction to hemostatic rebalancing therapy. Learn more about different treatment options for hemophilia with the
This video gives a quick introduction to gene therapy for hemophilia. Learn more about different treatment options for hemophilia with
This fact sheet contains commonly asked questions and more information on gene therapy for hemophilia A. Learn more about different
This fact sheet contains commonly asked questions and more information on hemostatic rebalancing therapy. Learn more about different treatment options
